Showing results (101-110 of 2,687) with videos related to
Sort By:
Pageof 269
Molecular and Cellular Biology|August 26, 2009
Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferationCaryll Waugh, Linda Sinclair, David Finlay, et al.Journal of Wildlife Diseases|October 28, 2023
Botulism in Two Juvenile Wild Red Foxes (Vulpes vulpes) in Somerset, England, UKAlexander M Barlow, Sarah Tingvoll, Emily Gover, et al.Plos Neglected Tropical Diseases|December 7, 2020
Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian childrenAmanda Gwee, Stephen Duffull, Xiao Zhu, et al.Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis StudiesHayley M Green, Daniel M J Fellner, David B Finlay, et al.Forensic Toxicology|August 23, 2016
The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activitiesMitchell Longworth, Samuel D Banister, James B C Mack, et al.Cannabis and Cannabinoid Research|September 2, 2017
Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and TwoJohn M McPartland, Christa MacDonald, Michelle Young, et al.Annals of Vascular Surgery|October 16, 2021
A Novel Approach for the Treatment of Nutcracker Syndrome: A Case ReportJacob Greenspan, David Szczerepa, Kaspar Trocha, et al.Journal of Molecular Endocrinology|October 13, 2006
A temporal switch in the insulin-signalling pathway that regulates hepatic IGF-binding protein-1 gene expressionDavid Finlay, Antonio J Ruiz-Alcaraz, Christopher Lipina, et al.Clinical Pharmacology and Therapeutics|November 24, 2019
Pharmacometrics and Systems Pharmacology 2030France Mentré, Lena E Friberg, Stephen Duffull, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2024
Oral docetaxel plus encequidar - A pharmacokinetic model and evaluation against IV docetaxelDavid Wang, Chris Jackson, Noelyn Hung, et al.Pageof 269